| pre-miRNA Information | |
|---|---|
| pre-miRNA | hsa-mir-7107 |
| Genomic Coordinates | chr12: 121444273 - 121444352 |
| Description | Homo sapiens miR-7107 stem-loop |
| Comment | None |
| RNA Secondary Structure |  |
| Mature miRNA Information | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mature miRNA | hsa-miR-7107-5p | ||||||||||||||||||||||||||||||
| Sequence | 6| UCGGCCUGGGGAGGAGGAAGGG |27 | ||||||||||||||||||||||||||||||
| Evidence | Experimental | ||||||||||||||||||||||||||||||
| Experiments | Meta-analysis | ||||||||||||||||||||||||||||||
| SNPs in miRNA |
|
||||||||||||||||||||||||||||||
| Putative Targets | |||||||||||||||||||||||||||||||
| miRNA Expression profile | |
|---|---|
| miRNAs in Extracellular Vesicles |
|
| Circulating MicroRNA Expression Profiling | |
| Gene Information | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene Symbol | CCND1 | ||||||||||||||||||||
| Synonyms | BCL1, D11S287E, PRAD1, U21B31 | ||||||||||||||||||||
| Description | cyclin D1 | ||||||||||||||||||||
| Transcript | NM_053056 | ||||||||||||||||||||
| Expression | |||||||||||||||||||||
| Putative miRNA Targets on CCND1 | |||||||||||||||||||||
| 3'UTR of CCND1 (miRNA target sites are highlighted) |
>CCND1|NM_053056|3'UTR 1 GGGCGCCAGGCAGGCGGGCGCCACCGCCACCCGCAGCGAGGGCGGAGCCGGCCCCAGGTGCTCCCCTGACAGTCCCTCCT 81 CTCCGGAGCATTTTGATACCAGAAGGGAAAGCTTCATTCTCCTTGTTGTTGGTTGTTTTTTCCTTTGCTCTTTCCCCCTT 161 CCATCTCTGACTTAAGCAAAAGAAAAAGATTACCCAAAAACTGTCTTTAAAAGAGAGAGAGAGAAAAAAAAAATAGTATT 241 TGCATAACCCTGAGCGGTGGGGGAGGAGGGTTGTGCTACAGATGATAGAGGATTTTATACCCCAATAATCAACTCGTTTT 321 TATATTAATGTACTTGTTTCTCTGTTGTAAGAATAGGCATTAACACAAAGGAGGCGTCTCGGGAGAGGATTAGGTTCCAT 401 CCTTTACGTGTTTAAAAAAAAGCATAAAAACATTTTAAAAACATAGAAAAATTCAGCAAACCATTTTTAAAGTAGAAGAG 481 GGTTTTAGGTAGAAAAACATATTCTTGTGCTTTTCCTGATAAAGCACAGCTGTAGTGGGGTTCTAGGCATCTCTGTACTT 561 TGCTTGCTCATATGCATGTAGTCACTTTATAAGTCATTGTATGTTATTATATTCCGTAGGTAGATGTGTAACCTCTTCAC 641 CTTATTCATGGCTGAAGTCACCTCTTGGTTACAGTAGCGTAGCGTGCCCGTGTGCATGTCCTTTGCGCCTGTGACCACCA 721 CCCCAACAAACCATCCAGTGACAAACCATCCAGTGGAGGTTTGTCGGGCACCAGCCAGCGTAGCAGGGTCGGGAAAGGCC 801 ACCTGTCCCACTCCTACGATACGCTACTATAAAGAGAAGACGAAATAGTGACATAATATATTCTATTTTTATACTCTTCC 881 TATTTTTGTAGTGACCTGTTTATGAGATGCTGGTTTTCTACCCAACGGCCCTGCAGCCAGCTCACGTCCAGGTTCAACCC 961 ACAGCTACTTGGTTTGTGTTCTTCTTCATATTCTAAAACCATTCCATTTCCAAGCACTTTCAGTCCAATAGGTGTAGGAA 1041 ATAGCGCTGTTTTTGTTGTGTGTGCAGGGAGGGCAGTTTTCTAATGGAATGGTTTGGGAATATCCATGTACTTGTTTGCA 1121 AGCAGGACTTTGAGGCAAGTGTGGGCCACTGTGGTGGCAGTGGAGGTGGGGTGTTTGGGAGGCTGCGTGCCAGTCAAGAA 1201 GAAAAAGGTTTGCATTCTCACATTGCCAGGATGATAAGTTCCTTTCCTTTTCTTTAAAGAAGTTGAAGTTTAGGAATCCT 1281 TTGGTGCCAACTGGTGTTTGAAAGTAGGGACCTCAGAGGTTTACCTAGAGAACAGGTGGTTTTTAAGGGTTATCTTAGAT 1361 GTTTCACACCGGAAGGTTTTTAAACACTAAAATATATAATTTATAGTTAAGGCTAAAAAGTATATTTATTGCAGAGGATG 1441 TTCATAAGGCCAGTATGATTTATAAATGCAATCTCCCCTTGATTTAAACACACAGATACACACACACACACACACACACA 1521 CAAACCTTCTGCCTTTGATGTTACAGATTTAATACAGTTTATTTTTAAAGATAGATCCTTTTATAGGTGAGAAAAAAACA 1601 ATCTGGAAGAAAAAAACCACACAAAGACATTGATTCAGCCTGTTTGGCGTTTCCCAGAGTCATCTGATTGGACAGGCATG 1681 GGTGCAAGGAAAATTAGGGTACTCAACCTAAGTTCGGTTCCGATGAATTCTTATCCCCTGCCCCTTCCTTTAAAAAACTT 1761 AGTGACAAAATAGACAATTTGCACATCTTGGCTATGTAATTCTTGTAATTTTTATTTAGGAAGTGTTGAAGGGAGGTGGC 1841 AAGAGTGTGGAGGCTGACGTGTGAGGGAGGACAGGCGGGAGGAGGTGTGAGGAGGAGGCTCCCGAGGGGAAGGGGCGGTG 1921 CCCACACCGGGGACAGGCCGCAGCTCCATTTTCTTATTGCGCTGCTACCGTTGACTTCCAGGCACGGTTTGGAAATATTC 2001 ACATCGCTTCTGTGTATCTCTTTCACATTGTTTGCTGCTATTGGAGGATCAGTTTTTTGTTTTACAATGTCATATACTGC 2081 CATGTACTAGTTTTAGTTTTCTCTTAGAACATTGTATTACAGATGCCTTTTTTGTAGTTTTTTTTTTTTTTATGTGATCA 2161 ATTTTGACTTAATGTGATTACTGCTCTATTCCAAAAAGGTTGCTGTTTCACAATACCTCATGCTTCACTTAGCCATGGTG 2241 GACCCAGCGGGCAGGTTCTGCCTGCTTTGGCGGGCAGACACGCGGGCGCGATCCCACACAGGCTGGCGGGGGCCGGCCCC 2321 GAGGCCGCGTGCGTGAGAACCGCGCCGGTGTCCCCAGAGACCAGGCTGTGTCCCTCTTCTCTTCCCTGCGCCTGTGATGC 2401 TGGGCACTTCATCTGATCGGGGGCGTAGCATCATAGTAGTTTTTACAGCTGTGTTATTCTTTGCGTGTAGCTATGGAAGT 2481 TGCATAATTATTATTATTATTATTATAACAAGTGTGTCTTACGTGCCACCACGGCGTTGTACCTGTAGGACTCTCATTCG 2561 GGATGATTGGAATAGCTTCTGGAATTTGTTCAAGTTTTGGGTATGTTTAATCTGTTATGTACTAGTGTTCTGTTTGTTAT 2641 TGTTTTGTTAATTACACCATAATGCTAATTTAAAGAGACTCCAAATCTCAATGAAGCCAGCTCACAGTGCTGTGTGCCCC 2721 GGTCACCTAGCAAGCTGCCGAACCAAAAGAATTTGCACCCCGCTGCGGGCCCACGTGGTTGGGGCCCTGCCCTGGCAGGG 2801 TCATCCTGTGCTCGGAGGCCATCTCGGGCACAGGCCCACCCCGCCCCACCCCTCCAGAACACGGCTCACGCTTACCTCAA 2881 CCATCCTGGCTGCGGCGTCTGTCTGAACCACGCGGGGGCCTTGAGGGACGCTTTGTCTGTCGTGATGGGGCAAGGGCACA 2961 AGTCCTGGATGTTGTGTGTATCGAGAGGCCAAAGGCTGGTGGCAAGTGCACGGGGCACAGCGGAGTCTGTCCTGTGACGC 3041 GCAAGTCTGAGGGTCTGGGCGGCGGGCGGCTGGGTCTGTGCATTTCTGGTTGCACCGCGGCGCTTCCCAGCACCAACATG 3121 TAACCGGCATGTTTCCAGCAGAAGACAAAAAGACAAACATGAAAGTCTAGAAATAAAACTGGTAAAACCCCAAAAAAAAA 3201 AAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
| miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
| DRVs in gene 3'UTRs | |||||||||||||||||||||
| SNPs in gene 3'UTRs | |||||||||||||||||||||
| Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| miRNA:Target | ---- | |||||||||
| Validation Method |
|
|||||||||
| Conditions | HEK293 | |||||||||
| Disease | 595.0 | |||||||||
| Location of target site | 3'UTR | |||||||||
| Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
| Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
|||||||||
| miRNA-target interactions (Provided by authors) |
|
|||||||||
| Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
|||||||||
| Experimental Support 2 for Functional miRNA-Target Interaction | |
|---|---|
| miRNA:Target | ---- |
| Validation Method |
|
| Conditions | MCF7 |
| Location of target site | 3'UTR |
| Tools used in this research | TargetScan , miRTarCLIP , Piranha |
| Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
| Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
| Experimental Support 3 for Functional miRNA-Target Interaction | |
|---|---|
| miRNA:Target | ---- |
| Validation Method |
|
| Conditions | Prostate Tissue |
| Location of target site | 3'UTR |
| Tools used in this research | TargetScan , miRTarCLIP , Piranha |
| Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760638. RNA binding protein: AGO2. Condition:AGO-CLIP-PC3-miR148
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
| Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
| CLIP-seq Support 1 for dataset GSM714644 | |
|---|---|
| Method / RBP | PAR-CLIP / AGO2 |
| Cell line / Condition | HEK293 / completeT1, repA |
| Location of target site | ENST00000227507.2 | 3UTR | AGGCCGCAGCUCCAUUUUCUUAUUGCGCUGCUACCG |
| Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
| Article / Accession Series | PMID: 21572407 / GSE28865 |
| CLIP-seq Viewer | Link |
| CLIP-seq Support 2 for dataset SRR1045082 | |
|---|---|
| Method / RBP | PAR-CLIP / AGO2 |
| Cell line / Condition | MCF7 / Untreated |
| Location of target site | ENST00000227507.2 | 3UTR | CAGGCCGCAGCUCCAUUUUCUUAUUGCGCUGCUACCG |
| Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
| Article / Accession Series | PMID: 24398324 / SRX388831 |
| CLIP-seq Viewer | Link |
| MiRNA-Target Expression Profile | |||||||
|---|---|---|---|---|---|---|---|
|
| MiRNA-Target Expression Profile (TCGA) | |||||||
|---|---|---|---|---|---|---|---|
|
144 hsa-miR-7107-5p Target Genes:
Functional analysis:
ID |
Target | Description | Validation methods |
 |
 |
|||||||
| Strong evidence | Less strong evidence | |||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
|||||
| MIRT060580 | CCND1 | cyclin D1 |  |
|
2 | 4 | ||||||
| MIRT451035 | ZNF610 | zinc finger protein 610 | |
|
2 | 2 | ||||||
| MIRT485711 | CASP16 | caspase 16, pseudogene | |
|
2 | 8 | ||||||
| MIRT488402 | TDRKH | tudor and KH domain containing | |
|
2 | 2 | ||||||
| MIRT492084 | TCF21 | transcription factor 21 | |
|
2 | 2 | ||||||
| MIRT504213 | VAV3 | vav guanine nucleotide exchange factor 3 | |
|
2 | 13 | ||||||
| MIRT505723 | SERTAD3 | SERTA domain containing 3 | |
|
2 | 4 | ||||||
| MIRT509007 | FBXO6 | F-box protein 6 | |
|
2 | 2 | ||||||
| MIRT509843 | FOS | Fos proto-oncogene, AP-1 transcription factor subunit | |
|
2 | 2 | ||||||
| MIRT514761 | RBM4B | RNA binding motif protein 4B | |
|
2 | 2 | ||||||
| MIRT515664 | LRRC27 | leucine rich repeat containing 27 | |
|
2 | 2 | ||||||
| MIRT516316 | F8A2 | coagulation factor VIII associated 2 | |
|
2 | 2 | ||||||
| MIRT516342 | F8A3 | coagulation factor VIII associated 3 | |
|
2 | 2 | ||||||
| MIRT517139 | KCTD21 | potassium channel tetramerization domain containing 21 | |
|
2 | 2 | ||||||
| MIRT518746 | C1orf35 | chromosome 1 open reading frame 35 | |
|
2 | 2 | ||||||
| MIRT519299 | MLH1 | mutL homolog 1 | |
|
2 | 2 | ||||||
| MIRT521527 | QSOX1 | quiescin sulfhydryl oxidase 1 | |
|
2 | 4 | ||||||
| MIRT531756 | TXK | TXK tyrosine kinase | |
|
2 | 2 | ||||||
| MIRT542208 | C14orf142 | GON7, KEOPS complex subunit homolog | |
|
2 | 2 | ||||||
| MIRT542235 | FUT9 | fucosyltransferase 9 | |
|
2 | 2 | ||||||
| MIRT542791 | PLEKHA3 | pleckstrin homology domain containing A3 | |
|
2 | 2 | ||||||
| MIRT554378 | SETD5 | SET domain containing 5 | |
|
2 | 2 | ||||||
| MIRT569908 | PCSK9 | proprotein convertase subtilisin/kexin type 9 | |
|
2 | 2 | ||||||
| MIRT570222 | SLC27A1 | solute carrier family 27 member 1 | |
|
2 | 2 | ||||||
| MIRT570976 | RGS19 | regulator of G protein signaling 19 | |
|
2 | 2 | ||||||
| MIRT573046 | SHMT1 | serine hydroxymethyltransferase 1 | |
|
2 | 2 | ||||||
| MIRT574954 | Vav3 | vav 3 oncogene | |
|
2 | 8 | ||||||
| MIRT609297 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | |
|
2 | 2 | ||||||
| MIRT612990 | GBX2 | gastrulation brain homeobox 2 | |
|
2 | 2 | ||||||
| MIRT613851 | SHB | SH2 domain containing adaptor protein B | |
|
2 | 2 | ||||||
| MIRT613935 | POLR3A | RNA polymerase III subunit A | |
|
2 | 2 | ||||||
| MIRT614243 | WDR53 | WD repeat domain 53 | |
|
2 | 4 | ||||||
| MIRT615158 | SPIB | Spi-B transcription factor | |
|
2 | 2 | ||||||
| MIRT616145 | HS3ST1 | heparan sulfate-glucosamine 3-sulfotransferase 1 | |
|
2 | 2 | ||||||
| MIRT616389 | C1orf87 | chromosome 1 open reading frame 87 | |
|
2 | 2 | ||||||
| MIRT617737 | ATCAY | ATCAY, caytaxin | |
|
2 | 4 | ||||||
| MIRT621449 | TCN2 | transcobalamin 2 | |
|
2 | 2 | ||||||
| MIRT625784 | GCNT1 | glucosaminyl (N-acetyl) transferase 1, core 2 | |
|
2 | 2 | ||||||
| MIRT628556 | MELK | maternal embryonic leucine zipper kinase | |
|
2 | 2 | ||||||
| MIRT632041 | ZNF430 | zinc finger protein 430 | |
|
2 | 2 | ||||||
| MIRT634937 | GTF2H2C | GTF2H2 family member C | |
|
2 | 4 | ||||||
| MIRT637208 | MEAF6 | MYST/Esa1 associated factor 6 | |
|
2 | 2 | ||||||
| MIRT637610 | LOH12CR1 | BLOC-1 related complex subunit 5 | |
|
2 | 2 | ||||||
| MIRT637832 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | |
|
2 | 2 | ||||||
| MIRT638107 | ZBTB43 | zinc finger and BTB domain containing 43 | |
|
2 | 2 | ||||||
| MIRT638387 | RAB11FIP1 | RAB11 family interacting protein 1 | |
|
2 | 2 | ||||||
| MIRT641689 | SPCS1 | signal peptidase complex subunit 1 | |
|
2 | 2 | ||||||
| MIRT642611 | APOPT1 | apoptogenic 1, mitochondrial | |
|
2 | 2 | ||||||
| MIRT643850 | LACTB | lactamase beta | |
|
2 | 4 | ||||||
| MIRT649575 | PALD1 | phosphatase domain containing, paladin 1 | |
|
2 | 2 | ||||||
| MIRT649860 | WDR12 | WD repeat domain 12 | |
|
2 | 2 | ||||||
| MIRT651026 | ZNF699 | zinc finger protein 699 | |
|
2 | 2 | ||||||
| MIRT652336 | TMOD3 | tropomodulin 3 | |
|
2 | 4 | ||||||
| MIRT653286 | SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | |
|
2 | 2 | ||||||
| MIRT656292 | METTL14 | methyltransferase like 14 | |
|
2 | 2 | ||||||
| MIRT656458 | MAPK14 | mitogen-activated protein kinase 14 | |
|
2 | 2 | ||||||
| MIRT659539 | CHCHD5 | coiled-coil-helix-coiled-coil-helix domain containing 5 | |
|
2 | 2 | ||||||
| MIRT661537 | NWD1 | NACHT and WD repeat domain containing 1 | |
|
2 | 2 | ||||||
| MIRT668042 | GTPBP10 | GTP binding protein 10 | |
|
2 | 2 | ||||||
| MIRT668147 | GDPD1 | glycerophosphodiester phosphodiesterase domain containing 1 | |
|
2 | 2 | ||||||
| MIRT668800 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | |
|
2 | 2 | ||||||
| MIRT669818 | STOML1 | stomatin like 1 | |
|
2 | 2 | ||||||
| MIRT670490 | DCUN1D2 | defective in cullin neddylation 1 domain containing 2 | |
|
2 | 2 | ||||||
| MIRT670615 | NPHP1 | nephrocystin 1 | |
|
2 | 2 | ||||||
| MIRT670892 | CYTIP | cytohesin 1 interacting protein | |
|
2 | 2 | ||||||
| MIRT670943 | LIPG | lipase G, endothelial type | |
|
2 | 2 | ||||||
| MIRT671268 | MTRNR2L5 | MT-RNR2-like 5 | |
|
2 | 2 | ||||||
| MIRT671903 | GBP4 | guanylate binding protein 4 | |
|
2 | 2 | ||||||
| MIRT672239 | ABHD15 | abhydrolase domain containing 15 | |
|
2 | 2 | ||||||
| MIRT672326 | C9orf3 | chromosome 9 open reading frame 3 | |
|
2 | 2 | ||||||
| MIRT673113 | MFSD2A | major facilitator superfamily domain containing 2A | |
|
2 | 2 | ||||||
| MIRT674412 | GNE | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | |
|
2 | 2 | ||||||
| MIRT677718 | IRF1 | interferon regulatory factor 1 | |
|
2 | 2 | ||||||
| MIRT678585 | PPP1R3B | protein phosphatase 1 regulatory subunit 3B | |
|
2 | 2 | ||||||
| MIRT678726 | SRCAP | Snf2 related CREBBP activator protein | |
|
2 | 2 | ||||||
| MIRT679338 | ISG20L2 | interferon stimulated exonuclease gene 20 like 2 | |
|
2 | 2 | ||||||
| MIRT679614 | RRP36 | ribosomal RNA processing 36 | |
|
2 | 2 | ||||||
| MIRT679695 | SLC1A5 | solute carrier family 1 member 5 | |
|
2 | 4 | ||||||
| MIRT679715 | RPL24 | ribosomal protein L24 | |
|
2 | 2 | ||||||
| MIRT680065 | CD96 | CD96 molecule | |
|
2 | 2 | ||||||
| MIRT683379 | ESR2 | estrogen receptor 2 | |
|
2 | 2 | ||||||
| MIRT683683 | MICA | MHC class I polypeptide-related sequence A | |
|
2 | 2 | ||||||
| MIRT683865 | OCIAD1 | OCIA domain containing 1 | |
|
2 | 2 | ||||||
| MIRT684073 | TLR7 | toll like receptor 7 | |
|
2 | 2 | ||||||
| MIRT684126 | CEP104 | centrosomal protein 104 | |
|
2 | 2 | ||||||
| MIRT684485 | GPR137B | G protein-coupled receptor 137B | |
|
2 | 2 | ||||||
| MIRT684736 | DNAJB13 | DnaJ heat shock protein family (Hsp40) member B13 | |
|
2 | 2 | ||||||
| MIRT684778 | MYO1F | myosin IF | |
|
2 | 2 | ||||||
| MIRT685028 | MRI1 | methylthioribose-1-phosphate isomerase 1 | |
|
2 | 2 | ||||||
| MIRT685189 | DCTN5 | dynactin subunit 5 | |
|
2 | 2 | ||||||
| MIRT685307 | ASB16 | ankyrin repeat and SOCS box containing 16 | |
|
2 | 2 | ||||||
| MIRT685514 | MSH3 | mutS homolog 3 | |
|
2 | 2 | ||||||
| MIRT685702 | BHMT2 | betaine--homocysteine S-methyltransferase 2 | |
|
2 | 2 | ||||||
| MIRT685944 | PTGIS | prostaglandin I2 synthase | |
|
2 | 2 | ||||||
| MIRT686311 | VPS53 | VPS53, GARP complex subunit | |
|
2 | 2 | ||||||
| MIRT686686 | TIMM10 | translocase of inner mitochondrial membrane 10 | |
|
2 | 2 | ||||||
| MIRT687641 | LRIF1 | ligand dependent nuclear receptor interacting factor 1 | |
|
2 | 2 | ||||||
| MIRT687923 | HOOK3 | hook microtubule tethering protein 3 | |
|
2 | 2 | ||||||
| MIRT688117 | GEMIN8 | gem nuclear organelle associated protein 8 | |
|
2 | 2 | ||||||
| MIRT688460 | DNAJB4 | DnaJ heat shock protein family (Hsp40) member B4 | |
|
2 | 2 | ||||||
| MIRT688629 | CRISPLD2 | cysteine rich secretory protein LCCL domain containing 2 | |
|
2 | 2 | ||||||
| MIRT688823 | CAPZA2 | capping actin protein of muscle Z-line alpha subunit 2 | |
|
2 | 2 | ||||||
| MIRT689117 | ZBTB25 | zinc finger and BTB domain containing 25 | |
|
2 | 2 | ||||||
| MIRT689166 | ZNF665 | zinc finger protein 665 | |
|
2 | 2 | ||||||
| MIRT690070 | MBD1 | methyl-CpG binding domain protein 1 | |
|
2 | 2 | ||||||
| MIRT690733 | IRAK4 | interleukin 1 receptor associated kinase 4 | |
|
2 | 2 | ||||||
| MIRT691324 | KIAA1841 | KIAA1841 | |
|
2 | 2 | ||||||
| MIRT691517 | ZNF682 | zinc finger protein 682 | |
|
2 | 2 | ||||||
| MIRT691607 | IPP | intracisternal A particle-promoted polypeptide | |
|
2 | 2 | ||||||
| MIRT692314 | RFK | riboflavin kinase | |
|
2 | 2 | ||||||
| MIRT692376 | LY6G5B | lymphocyte antigen 6 family member G5B | |
|
2 | 2 | ||||||
| MIRT692436 | METTL8 | methyltransferase like 8 | |
|
2 | 2 | ||||||
| MIRT692782 | SYNPO2L | synaptopodin 2 like | |
|
2 | 2 | ||||||
| MIRT693136 | THEM4 | thioesterase superfamily member 4 | |
|
2 | 2 | ||||||
| MIRT693422 | TECPR2 | tectonin beta-propeller repeat containing 2 | |
|
2 | 2 | ||||||
| MIRT693871 | COX19 | COX19, cytochrome c oxidase assembly factor | |
|
2 | 2 | ||||||
| MIRT694049 | PRIM1 | DNA primase subunit 1 | |
|
2 | 2 | ||||||
| MIRT694092 | KIAA0930 | KIAA0930 | |
|
2 | 2 | ||||||
| MIRT694190 | ZNF347 | zinc finger protein 347 | |
|
2 | 2 | ||||||
| MIRT695177 | SLC25A33 | solute carrier family 25 member 33 | |
|
2 | 2 | ||||||
| MIRT696180 | GNB5 | G protein subunit beta 5 | |
|
2 | 2 | ||||||
| MIRT697387 | ZMAT3 | zinc finger matrin-type 3 | |
|
2 | 2 | ||||||
| MIRT698924 | SPEM1 | spermatid maturation 1 | |
|
2 | 2 | ||||||
| MIRT699314 | SLC35F5 | solute carrier family 35 member F5 | |
|
2 | 4 | ||||||
| MIRT701106 | PAPD5 | poly(A) RNA polymerase D5, non-canonical | |
|
2 | 2 | ||||||
| MIRT701575 | MYPN | myopalladin | |
|
2 | 2 | ||||||
| MIRT701825 | MRPL37 | mitochondrial ribosomal protein L37 | |
|
2 | 2 | ||||||
| MIRT702047 | METTL21A | methyltransferase like 21A | |
|
2 | 2 | ||||||
| MIRT703034 | HAS2 | hyaluronan synthase 2 | |
|
2 | 4 | ||||||
| MIRT704143 | DNAL1 | dynein axonemal light chain 1 | |
|
2 | 2 | ||||||
| MIRT704759 | CDKN2AIPNL | CDKN2A interacting protein N-terminal like | |
|
2 | 2 | ||||||
| MIRT705079 | C4orf29 | abhydrolase domain containing 18 | |
|
2 | 2 | ||||||
| MIRT705346 | ATP1B3 | ATPase Na+/K+ transporting subunit beta 3 | |
|
2 | 2 | ||||||
| MIRT706104 | ENTPD4 | ectonucleoside triphosphate diphosphohydrolase 4 | |
|
2 | 2 | ||||||
| MIRT709070 | FAHD1 | fumarylacetoacetate hydrolase domain containing 1 | |
|
2 | 2 | ||||||
| MIRT709534 | ZBED1 | zinc finger BED-type containing 1 | |
|
2 | 2 | ||||||
| MIRT712356 | NAT14 | N-acetyltransferase 14 (putative) | |
|
2 | 2 | ||||||
| MIRT713713 | PAOX | polyamine oxidase | |
|
2 | 2 | ||||||
| MIRT714304 | ZNF454 | zinc finger protein 454 | |
|
2 | 2 | ||||||
| MIRT714919 | PPP1R12C | protein phosphatase 1 regulatory subunit 12C | |
|
2 | 2 | ||||||
| MIRT715792 | TBL3 | transducin beta like 3 | |
|
2 | 2 | ||||||
| MIRT717376 | RBM41 | RNA binding motif protein 41 | |
|
2 | 2 | ||||||
| MIRT719069 | ACOX1 | acyl-CoA oxidase 1 | |
|
2 | 2 | ||||||
| MIRT724548 | HAUS2 | HAUS augmin like complex subunit 2 | |
|
2 | 2 | ||||||
| miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|